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ABSTRACT 
Objective: The objective of this present work was to develop the chemical peeling cream containing the synthesized active ingredient 
pharmaceutical cocrystal of salicylic acid and phenylalanine. 
Methods: The salicylic acid and phenylalanine cocrystal (H2
Results: The (H
Sal•Phe) was synthesized by the solvent evaporation method and characterized by 
various techniques such as single-crystal X-ray diffraction and Fourier transform infrared spectroscopy. The five formulas of cocrystal cream were 
prepared. All formulas were then examined and observed for appearance, spreadability, viscosity, pH, homogeneity, SPF test, microbial limit test 
and stability test. 
2Sal•Phe) consists of no zwitterion phenylalanine for the first time. X-ray crystal structure of cocrystal consists of double H2Sal and 
Phe molecules with stabilized by inter-, intra-molecular and π-π interactions. By using this cocrystal as an active ingredient for cosmetic 
development, the chemical peeling cream was produced along with the pharmaceutical examinations. The (H2Sal•Phe) formulations were prepared 
0-1% and excipients included of jojoba oil, isopropyl myristate, castor oil, glyceryl monostearate cetostearyl alcohol, cyclomethicone (and) 
dimethicone crosspolymer, vitamin E, white bee's wax, glycerin, PEG 400, xanthan gum, Span 80 and Tween 60. We finally found that the F4 (1% 
H2Sal•Phe) was the best formulation with suitable physical properties of cream and chemical stable after storage. The results of cell viability show 
H2
Conclusion: The chemical peeling cream containing (H
Sal•Phe is non-toxic with cell. 
2Sal•Phe) has shown the promising results which are both safe and efficacious peeling agent. 
Cocrystal (H2
Keywords: Pharmaceutical cocrystal, Salicylic acid, Phenylalanine, Cream, Cosmetics, Formulation development 
Sal•Phe) cream can be used as an alternative choice in whitening skin. 





Various preparations of salicylic acid have been used for peeling 
purposes for up to 50% [4]. The indications of a salicylic acid peeling 
agent include acne vulgarism, melasma, post-inflammatory 
hyperpigmentation, freckles, lentigines, mild to moderate of 
photodamage, texturally roughened skin and fine wrinkle [4]. 
Marketed salicylic acid does not seem to be effective in exfoliating 
compared with glycolic acid (8-15%) that is commercially available 
and cheaper [5]. Phenylalanine is an essential amino acid which is a 
building block for proteins in the body [6]. It may be used in 
cosmetics as well as personal care products, such as topical cream 
which use to help turn over the pigment-forming melanocytes which 
are essential in the initiation of pigmentation [1, 6-8]. A chemical 
peel is used for cosmetics skin improvements [8]. It is known as 
salicylic acid chemical peels, alpha hydroxy acid (AHA) chemical 
peels, or glycolic acid peels which is
Sal) is not only a beta-hydroxy acid but also non-
steroidal anti-inflammatory drug (NSAID) [1-3]. It is a hydroxyl 
derivative of benzoic acid and represents a carboxylic acid attached 
to aromatic alcohol, phenol [1]. It also is known as skin disorder 
treatments such as keratolytic properties because of the solubility of 
intracellular cement. Its lipid solubility permits the interaction with 
multilamellar structures surrounding the keratinocytes in the 
stratum corneum and hair follicle, thereby exhibiting follicular 
atrophy and comedolytic action within the sebaceous unit [1]. 
 the application of a chemical 
agent to the skin [7, 8]
In order to improve the physicochemical properties of APIs, 
pharmaceutical cocrystals can be used as an alternative approach to 
enhancing specific physical properties of pharmaceutical ingredients 
[13-15]. Cocrystals of salicylic acid with other organic compounds 
have been reported for many applications for examples: to develop 
thermal methods [16], searching for marketing drugs [3], treatment 
melisma [17]. The cocrystals of salicylic derivatives with amino acid 
have also been reported in many pharmaceutical applications too 
[7]. 
. The ingredients and formulation of a light 
chemical peel, however, depend on the specific patient’s skincare 
needs. With light chemical peels, the chemical solution is left on the 
skin for a relatively short amount of time. In general, chemical peels 
can improve the skin's appearance [1,8,9]. Pharmaceutical 
cocrystallization is crystalline molecular complexes containing 
therapeutic molecules for the development of the active 
pharmaceutical ingredient (API) drugs [10, 11]. Cocrystals are 
generally formed through noncovalent interaction bonds (primarily 
hydrogen bonding), π–π stacking, van der Waals interactions and 
other weak interactions [10-12].  
To the best of our knowledge, there are only two reports on the 
cocrystal of salicylic acid and phenylalanine amino acid. The first one 
reported as power phase of H2Sal•Phe with no report on 
pharmaceutical cosmetics [18, 19]. Another cocrystal reported as 
zwitterions cocrystal. The preparations of salicylic acid are wildly 
prepared in a topical dosage form such as cream, gel, ointment and 
paste [4, 20, 21]. There is no report on the development of salicylic 
cocrystal as a topical preparation. Therefore, the main objective of 
this work was to synthesize the neutral cocrystal and to study the 
feasibility and produce chemical peeling cream from cocrystal 
(H2
MATERIALS AND METHODS 
Sal•Phe). 
Chemicals and reagents 
All the excipients used in this study were of analytical grade. 
Salicylic acid and phenylalanine were obtained from Sigma-Aldrich 
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and used without purification. Jojoba oil, isopropyl myristate, castor 
oil, cyclomethicone (and) dimethicone cross polymer, vitamin E, 
glycerin, PEG 400, xanthan gum, Span 80 and Tween 60 were 
obtained from S. Tong Chemical Co., Ltd., Bangkok, Thailand. 
Glyceryl monostearate, white bee’s wax, and cetostearyl alcohol 
were purchased from Namsiang, Bangkok, Thailand. All the 
excipients used in this study were of pharmaceutical or analytical 
grade. 
Synthesis of cocrystal H2
In the typical procedure, pharmaceutical cocrystals (H
Sal•Phe 
2Sal•Phe) 
were synthesized by the solvent evaporation method [10,11]. 
Cocrystal (H2
 
Sal•Phe) was synthesized by reacting salicylic acid 
with phenylalanine in the 1:1 mole ratios at 50 °C as tabulated in 
table 1. The final pH was 2. After a few days, the colorless crystals 
were obtained with a percent yield of 85. 
Table 1: The synthesis of cocrystal (H2
Starting materials 
Sal•Phe) 
M. W. (g/mol) Mole ratio Temp. ( °C) Solvent Volume (ml) 
H2 138.12 Sal 1 50 EtOH 5 
Phe 165.19 1 50 Water 10 
 
Single crystal X-ray structure determination 
X-ray diffraction studies were carried out at 296(2) K on an APEX2 
CCD diffractometer equipped with graphite monochromated Mo Kα 
radiation (λ = 0.71073 Å). The SAINT program was used for data 
collection, cell refinement and data reduction. The SADABS program 
applied only cocrystal refinement [22]. The structures were solved 
by direct methods using Shelxs97 and the structured refined against 
F2 for all reflections by full matrix methods in Shelxl97. All non-
hydrogen atoms were refined anisotropically and the hydrogen 
atoms were placed in geometric positions and refined as the riding 
model atoms with C-H = 0.93 Å and Uiso(H)= 1.2 Ueq(C). Program 
Mercury and Diamond were used to demonstrate the fig. 2-3. 
Fourier transform infrared spectra (FT-IR)  
FT-IR was recorded on a Bruker OPUS 7. The FT-IR sample spectra 
measurements were prepared as potassium bromide (KBr) discs in 
the region 4000-400 cm-1.  
Ultraviolet-visible spectra (UV-Vis)  
UV-Vis of starting materials and cocrystal dissolving in the ethanol 
was measured using the Shimadzu UV-1601 spectrophotometer 
over the range of 800 to 190 nm.  
Preparation of chemical peeling cream from cocrystal 
H2
To adjust the formula to get the right cream, we investigated both the 
oil phase and the water phase. At the development process, we choose 
the oil phase which contains such as jojoba oil, isopropyl myristate, 
glyceryl monostearate, and the water phase which contains glycerin 
and tween. It produced quite a hard cream and not stable after freeze-
thaw. After trial for cream preparation, we developed and found that 
the suitable way to produce cream containing the mixtures of jojoba 
oil, isopropyl myristate, castor oil, glyceryl monostearate cetostearyl 
alcohol, cyclomethicone (and) dimethicone crosspolymer, vitamin E, 
white bee's wax, glycerin, polyethylene glycol 400 (PEG 400), xanthan 
gum and sorbitan monostearate 80 (Span
Sal•Phe 
® 80) and polysorbate 60 
(Tween®
The cocrystal (H
 60) as emulsifier. 
2Sal•Phe) as an active ingredient which was 
dissolved in the water phase. Oil in water emulsion creams (control 
formulation and a formulation containing the H2Sal•Phe) were 
formulated by the beaker method [23, 24]. Glyceryl monostearate, 
white bee’s wax, and cetostearyl alcohol were dissolved in the oil 
phase (jojoba oil, isopropyl myristate, castor oil, cyclomethicone 
(and) dimethicone crosspolymer) and heat to 70±2°C. Xanthan gum 
was slowly dispersed with continuous agitation in purified water 
until a clear solution was obtained. At the same time, the ingredients 
in the water phase (glycerin, PEG 400 and paraben concentrate) 
were dissolved in purified water and then heat to 75±2°C. The 
emulsions were stabilized by Span 80 and Tween 60. After heating 
the cream was prepared by the addition of the aqueous phase to the 
oily phase with continuous agitation. Mixing was carried out by the 
mechanical mixer for 10 min until the complete aqueous phase was 
added. Finally, a few drops of vitamin E were added during this 
stirring time to the formulations and then cream was homogenized 
with a small homogenizer at 3000 rpm for 10 min. Control 
formulation was also prepared by the same above method but 
without H2Sal•Phe (the active ingredient) and served as a control 
with compensating the amount of API by purified water. The 
pharmaceutical cocrystal (H2
 
Sal•Phe) was varied from 0% (control 
formula) and up to 1% w/w. The full list of the cream formulations 
was shown in table 2. Finally, the finished product will be specified. 




F1 F2 F3 F4 F5 
Cocrystal (H2 0.25 Sal•Phe) 0.50 0.75 1.00 - 
Jojoba oil 1.20 1.20 1.20 1.20 1.20 
Isopropyl myristate 2.00 2.00 2.00 2.00 2.00 
Castor oil 1.20 1.20 1.20 1.20 1.20 
Glycery monostearate 1.00 1.00 1.00 1.00 1.00 
Cetostearyl alcohol 2.00 2.00 2.00 2.00 2.00 
Cyclomethicone (and) dimethicone crosspolymer 5.00 5.00 5.00 5.00 5.00 
Vitamin E 2.00 2.00 2.00 2.00 2.00 
Sorbitan monostearate 80 (Span 2.00  80) 2.00 2.00 2.00 2.00 
White bee's wax 0.80 0.80 0.80 0.80 0.80 
Paraben concentrate (methylparaben 10% and propylparaben 2% in propylene glycol) 1.00 1.00 1.00 1.00 1.00 
Glycerine 1.00 1.00 1.00 1.00 1.00 
PEG 400 1.00 1.00 1.00 1.00 1.00 
Xanthan gum 0.80 0.80 0.80 0.80 0.80 
Polysorbate 60 (Tween 1.00  60) 1.00 1.00 1.00 1.00 
Purified water 77.75 77.50 77.25 77.00 78.00 
 
Appearance  
A cream containing cocrystal (H2Sal•Phe) and control (F1-F5) were 
examined organoleptically after freshly prepared and after the 
centrifugal test (odor, color, thickness, look, feel) and physically 
(creaming, sedimentation and phase separation). Type of emulsions 
was determined microscopically (see dye solubility test). The 
standard colors such as pure white, white, signal white, slightly 
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yellow, off white, light gray and other from pantone paper will be 
used to the comparison of the cream description. 
Homogeneity 
Homogeneity of various formulations was tested by visual observation 
according the scale reported by a previous study [25] and was ranked 
as follows: +++= Excellent,++= Very Good,+= Good,-= Poor  
The criterion of homogeneity and texture was assessed by pressing a 
small quantity of the formulated cream between thumb and index 
finger. The excellent cream show 1-non greasy, 2-quickly absorbed, 
3-presence soft and smooth texture and 4-no defect of emulsion 
unstable such as creaming or cracking. Very good show only 1 point 
of defect, good is 2 point defect. The resulting cream show stiffness, 
grittiness or greasiness is fall in the poor assessment. 
pH measurement 
The pH of freshly prepared emulsions and emulsions kept at 
different storage conditions were determined by a digital pH-meter 
(Metrohm, Switzerland). About 0.5 gram of cream was dissolved 
with purified water and adjust to 50 ml volume. This 1% cream was 
asses the pH value [23, 26]. The pH determinations were carried out 
in triplicate and the mean was recorded. 
Dye solubility test  
One drop of cream mixed with a water-soluble dye such as amaranth and 
observed under the microscope. If the continuous phase appears red, 
then it means that the emulsion is o/w type. Again, if the scattered 
globules appear red and continuous phase colorless, then it is w/o type 
[21]. 
Viscosity test 
In order to determine the viscosity values (in Pa⋅s), rheological 
measurements were performed using Brookfield DV III ultra V6.0 RV 
cone and plate rheometer (Brookfield Engineering Laboratories, 
Middleboro, Massachusetts) using spindle #CPE40 at 25±0.5 °C. The 
measurements were carried out in triplicate at 25±2 °C, the average 
values are presented. 
Spreadability  
Spreadability is a term expressed to denote the extent of the area to 
which the cream readily spreads on application to the skin. 
Spreadability test equipment made in house by adapted from previous 
reference [26, 27]. The spreadability was expressed in terms of time in 
seconds taken by two slides to slip off from the cream, placed in 
between the slides, under a certain load. Lesser the time is taken for 
separation of the two slides, better the spreadability. Two glass slides 
of standard dimensions (7.5 x 2.5 cm) were selected. The sample 
formulation (1 g) whose spreadability had to be determined was 
placed over one of the slides. The other slide was placed on top of the 
formulations was sandwiched between the two slides across the 
length of 5 cm along the slide. 100 g weight was placed upon the upper 
slide so that the formulation between the two slides was pressed 
uniformly to form a thin layer. The weight was removed and the excess 
of formulation adhering to the slides was scrapped off. One of the 
slides was fixed on which the formulation was placed. The second 
movable slide was placed over it, with one end tied to a string to which 
load could be applied by the help of a simple pulley and a pan. A 30 g 
weight was put on the pan and the time taken for the upper slide to 
travel the distance of 5.0 cm and separate away from the lower slide 
under the direction of the weight was noted. The spreadability was 





Where m is a weight tied to the upper slide (30 g), l is the length of a 
glass slide (5 cm) and t is time taken in seconds. 
Assay content of salicylic acid in a cream containing cocrystal 
(H2
The content of salicylic acid in cream preparation was analyzed by 
HPLC according to a previous report [28]. Briefly, a Waters detector 
(Waters, Milford, USA) was used for HPLC analysis. Cream samples 
were dissolved with mobile phase and filtered through 0.45 µm 
nylon membrane filter. Chromatographic analysis was performed 
and processed with Empower v.2.0 software (Waters, Milford, USA). 
The chromatographic system was using a C18 column (5µm, 250 × 
4.6 mm i.d.). The mobile phase consists of acetonitrile: 0.05% 
trifluoroacetic acid aqueous solution (30:70) and the flow rate was 
set at 1.0 ml/min. The sample was injected 5 µL. The UV detector 
was set at 230 nm. 
Sal•Phe) 
In vitro SPF test 
The photoprotective efficacy was assessed in vitro by determining 
the sun protection factor (SPF) value of the formulations, which was 
calculated from SPF analyzer (Optometrics LLC/SPF-290F, USA). 
Divide all each sample from containers into beakers, followed by 
continuous stirring until the homogeneous appeared. After that, the 
homogenous sample was divided into a few more beakers with the 
continuous stirring yield for homogeneous. After completion, 
labeling the sample and packed in a glass bottle, cover and avoid the 
light. Each formulation was spread (2 mg/cm2) over a PMMA 
(polymethyl methacrylate) plates (70.7 mm2
Stability test 
) with a fingertip. The 
plate samples were then allowed to dry for 15 min protected from 
the light, and exposed to a xenon arc solar simulator. Measurements 
were made under the following laboratory conditions at 24.0±0,5 °C 
and 50-60% relative humidity. The measurement was performed by 
9 different scanning spots on each sample at 2 nm interval between 
290-400 nm. UVB protection efficacy as SPF, UVA protection efficacy 
as the Boot star rating and critical wavelength was recorded. As a 
blank reference representing 100% light transmission, an intact, not 
coated, PMMA plate was used [29]. All of the measurements were 
undertaken in triplicates. 
The stability of cream containing cocrystal (H2
(1) Centrifugation tests: Centrifugal tests were performed for 
emulsions immediately after preparation. Those tests were repeated 
after 1 d, 7 d, 14 d, 21 d, and 28 d and 60 d of preparation. They were 
performed at 5000 rpm and 25°C for 10 min by placing 5 g of each 
sample in centrifugal tubes [27, 30, 31]. 
Sal•Phe) was 
performed in 3 conditions. After freshly prepare the cream, the 50 g 
product was filled in plastic LDPE tube and analyzed the stability 
following:  
(2) Freeze and thaw cycle: Freeze and thaw treatment of the cream 
emulsion was performed immediately after preparation. Samples 
(20 g) were stored at 4±2 °C for 48 h. Then, samples were 
subsequently thawed at 40±2°C for 48 h. This test was carried out in 
triplicate for each sample. The physical appearance of cream was 
observed after finished 6 cycles [31]. 
(3) Long-term stability study: The samples were carried out in a 
stability chamber. The storage condition was 30±2 °C and 75±5%RH 
for 1, 3, 6 mo. Color, phase separation and liquefaction of emulsions 
were observed [32]. 
Microbial limit test  
The microbial limit test included of aerobic plate count, the content 
of Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus 
(S. aureus), yeast and mold count was performed according to [33]. 
One gram of cream was dispersed in a 4 ml sterile Ringer’s solution 
containing 0.25% Tween
(1) Aerobic plate count: aerobic plate counts were determined by 
inoculating 0.1 ml of the homogenate sample onto triplicate sterile 
plates of pre-poured and dried Standard Method Agar. Then, the plates 
were incubated for 48 h at 35 °C. Duplicates of each dilution (1 ml) of 
neutralized and non-neutralized samples were pour-plated using 
Standard Method Agar (Oxoid, Basingstoke, Hampshire, England) and 
incubated at 30 °C for 48 h. Plates containing 25–250 colonies were 
counted and the average number of CFU/g was calculated. 
 80. Six dilutions were made in the same 
dispersing vehicle, and 0.1 ml was placed out on the appropriate 
solid medium using the surface viable method. The test was 
performed following:  
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(2) Pseudomonas aeruginosa count: P. aeruginosa were enumerated on 
Pseudomonas Agar Base (CM 559, Oxoid) supplemented with Fucidin, 
cephaloridine, and cetrimide, providing a selective medium for P. 
aeruginosa. Colonies were counted after two days of incubation at 25 °C. 
(3) Staphylococcus aureus: Population of S. aureus was determined 
by standard plating methods. Colonies of Staphylococcus were 
selected, gram-stained, and observed for oxidase and catalase 
reactions to confirm their presence. All microbial counts were 
transformed into logarithms of the number of colony-forming units 
(log 10 CFU/g). 
(4) Yeast and mold count: The method involved enumeration of 
colonies on the Sabouraud dextrose chloramphenicol agar medium. 
Enumeration was carried out as a pour plate, surface spread, or 
membrane filtration method. Microbiological tests were repeated for 
formulations at 25 °C after 0, 7, 14, 21 and 28 d of preparation. 
Emergent colonies were counted after the necessary incubation. All 
operations were carried out in duplicates. 
Cell viability of the fibroblast with (H2Sal•Phe) 
This test was performed according to a previous study [34]. The 
human skin fibroblast cell line (BJ, ATCC: CRL-2522, VA, USA) and 
human skin keratinocyte cell line (HaCaT, CLS 300493, Eppelheim, 
Germany) diluted to 1 × 105 cells ml-1in Eagle’s Minimum Essential 
Medium (EMEM, Gibco, USA) for BJ and Dulbecco’s Modified Eagle’s 
Medium (DMEM, Gibco, USA) for HaCaT, respectively, were seeded 
into 96 well plates. Both the media were supplemented with 10% fetal 
bovine serum (FBS, Gibco, NY, USA), 50 units ml-1 of penicillin and 50 
μg ml-1 of streptomycin and the plates were incubated at 37 °C in 5% 
CO2. After 24 h, the culture media in the plates were replaced with 
fresh media. The 0.05% cocrystal (Phe•H2Sal in the fresh medium 
were added into the culture plate and non-treated cells served as 
controls. After 24 h incubation, 3-(4,5-dimethylthiazolyl-2-yl)-
diphenyltetrazolium bromide (MTT) assay was performed to evaluate 
the metabolic activity of treated and control cells. Briefly, the cells 
were treated with 100 μl of fresh media along with 50 μl of MTT 
solution (5 mg ml-1) and incubated at 37 °C under 5% CO2 for 4 h. After 
removal of the MTT containing media and addition of 100 μl of DMSO, 
the absorbance was determined by a microplate reader (Biohit 830, 
Biohit, Finland) at a wavelength of 570 nm. The percentage of cell 
proliferation was calculated for 10 cell passage and compared to the 
respective controls. 
Patch test  
The skin irritation test was used to evaluate the skin irritation by the 
preparation cream to the intact skin. In this research, 10 women 
volunteers to apply the selected chemical peeling cream (formula 
F4) and compared them with other 10 women as a control that used 
chemical peeling cream without cocrystal (H2
In order to investigate the product satisfaction, we choose 10 normal 
skin women (as the same of the patch test group) to evaluate our 
product through a questionnaire after usage once a day until day 7. 
The method for applying the cream was done with adaptation from 
[35]. Before testing, the volunteers washed their hands with tap 
water and dried them with paper towels for 5 min. afterward, the 
volunteers squeeze about 1 g of cream from the tube which they 
gently rubbed onto the back of their hand with their index finger. 
This rubbing was done 10 times in a circular motion. The volunteers 
left the cream for 5 min and they used an assessment sheet to assess 
aspects of cream. Afterward, they used tap water to rinse off the area 
where the cream had been applied. The questionnaires consist of the 
evaluate of odor, color, appearance, spreadability after applied on 
skin, viscosity and brightening. The five-rating scale used a scale that 
ranged from 1 (very poor satisfied) to 5 (strongly satisfied). 
Additionally, the developed product was compared satisfaction with 
the commercial product by the blinded experiment. 
RESULTS AND DISCUSSION 
Synthesis result, physical property and X-ray structure  
We successfully prepared the crystals of the 1:1 (salicylic acid: 
phenylalanine) mole ratio, with solvent evaporation [10, 11]. The way of 
preparation is not different from the previous report, but we obtained 
single crystal instead of power phase [16, 18, 19]. This is to confirm that 
the solvent evaporation method can be broken and reformed under 
these conditions. As known, free H
Sal•Phe) (formula F5). 
All volunteers were informed of objectives, test procedures, and 
possible adverse effects, and rewarded for their participation. These 
volunteers have the right to withdraw from the study at any time 
without penalty and consequence. The results of pass patch test 
showed that no edema or erythema occurred in all 20 volunteers 
within 48 h. This experiment was approved by the ethical committee 
of the university. 
Product satisfaction 
2Sal and Phe are the better solubilities 
in alcohol, ether and chloroform than water [36]. This cocrystal 
(H2Sal•Phe) was well dissolved in ethanol and dimethyl sulfoxide, but 
slightly soluble in acetone and hexane. (H2
 
Fig. 1: Cocrystal (H
Sal•Phe) cocrystal 




A single-crystal X-ray structural analysis shows that cocrystal 
crystalizes in the triclinic system with the space group P-1 as listed 
in table 3. The empirical formula of this cocrystal is C20H20N4O12 
which consists of two salicylic acid and two phenylalanine 
formulated as (H2Sal•Phe)2
 
. This is to confirm that the asymmetric 
unit contains 2 molecules per unit cell. 
 
Fig. 2: Molecular structure of cocrystal (H2Sal•Phe) with the 
atomic numbering scheme
Phetmung et al. 
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CCDC  1545143 
Empirical formula  C20 H20 N4 O
Formula weight  
12 
508.40 
Wavelength (Å)  0.71073  
Crystal system  Triclinic 
Space group  P-1 
Unit cell  a = 5.9141(8) Å, α = 83.939(5) ° 
 b =15.912(3) Å, β = 80.427(5) ° 
 c 16.165(3) Å, γ= 86.846(5) ° 
V (Å3) 1490.5(4) 
Z 2 
Density (calculated) (mg/m3) 1.133 
Absorption coefficient (mm-1) 0.095 
F(000) 528 
Theta range for data collection ( °) 1.28-25.19 
Independent reflections 4335 [R(int) = 0.0434] 
Completeness θ = 25.10 ° 99.8 %  
Absorption correction SADABS 
Refinement method Full-matrix least-squares on F2 
Data/restraints/parameters 4335/0/397 
Goodness-of-fit on F2 0.901 
Final R indices [I>2σ(I)] R1  = 0.0654, ωR2
R indices (all data) 
 = 0.1623 
R1  = 0.1707, ωR2 = 0.2350 
 
Table 4: Selected bond lengths [Å] and bond angles [°] of cocrystal (H2
Atoms 
Sal•Phe) 
Bond lengths [Å] Atoms Bond angles [ °] 
O(11)-C(11) 1.312(6) O(12)-C(11)-O(11) 122.8(5) 
O(12)-C(11) 1.230(6) O(11)-C(11)-C(12) 114.5(5) 
O(13)-C(13) 1.346(6) C(13)-C(12)-C(17) 119.1(5) 
O(21)-C(21) 1.309(6) C(13)-C(14)-C(15) 120.0(6) 
O(22)-C(21) 1.228(6) O(22)-C(21)-O(21) 121.5(5) 
O(23)-C(23) 1.360(7) O(22)-C(21)-C(22) 122.6(5) 
O(31)-C(31) 1.262(6) O(21)-C(21)-C(22) 115.9(5) 
O(32)-C(31) 1.240(6) C(23)-C(22)-C(21) 120.3(5) 
O(41)-C(41) 1.245(6) O(23)-C(23)-C(24) 117.1(5) 
O(42)-C(41) 1.260(6) O(32)-C(31)-O(31) 126.0(5) 
N(31)-C(32) 1.492(6) O(32)-C(31)-C(32) 119.2(5) 
N(41)-C(42) 1.476(6) O(31)-C(31)-C(32) 114.8(5) 
C(11)-C(12) 1.472(8) N(31)-C(32)-C(31) 108.8(4) 
C(12)-C(17) 1.392(7) N(31)-C(32)-C(33) 107.8(4) 
 
The x-ray parameter is in table 3. Selected bond lengths, bond 
angles, and torsion angles are listed in table 4. The hydrogen bond 
and weak interactions are shown in table 5. As seen in table 4, the C-
O-H of phenolic groups is longer than those of carboxylic groups 
such as 1.346(6)Å vs. 1.312(6)Å, confirming the cocrystal stability 
[10]. The packing diagram showed the inter-and intra-molecular 
interactions which are summarized in table 5. Undoubtedly, 
hydrogen bonding plays as important roles to form the building 
block units known as supramolecular synthons of motif, illustrated 
in fig. 3. 
 
Table 5: Weak interaction of cocrystal (H2
Code 
Sal•Phe) 
D-H d(D-H) d(H. A) <DHA d(D. A) A 
(a)  O11-H11  0.820 1.818 169.68 2.629 O42 [-x+1,-y+1,-z+1 ] 
(b) O13-H13A 0.820 1.895 145.00 2.609 O12 
(c) O21-H21 0.820 1.777 172.18 2.592 O31 [ x-1, y, z ] 
(d) O23-H23A 0.820 1.876 145.85 2.595 O22 
(e) O31-H31 0.820 1.967 168.28 2.775 N31 [ x+1, y, z ] 
(f) N31-H31A 0.860 2.293 131.70 2.937 O32 [-x+1,-y+2,-z+1 ] 
(g) N31-H31B 0.860 1.927 168.14 2.775 O31 [ x-1, y, z ] 
(h) N41-H41A 0.860 1.962 162.43 2.555 O12 [ x, y, z ] 
(i) N41-H41B 0.860 1.962 164.25 2.799 O32 [ x, y-1, z ] 
 
The packing diagram revealed that cocrystal consists of the 
intramolecular hydrogen bonding of Phe, intermolecular hydrogen 
bonding and pi-pi interactions of H2
FT-IR spectra 
Sal and Phe rings as shown in 
fig. 3. It is clear that this cocrystal can be stable through the weak 
interaction between donor and acceptor atoms within a length of at 
least 3.00 Å. 
As seen in fig. 4, the vibration spectra confirmed their components. The 
broad band over 2000 cm-1 indicated the weak interaction such as 
homosynthons which is in good agreements with interaction appeared 
in fig. 3. For the salicylic acid, the O-H, C-H aromatic vibration bands are 
Phetmung et al. 
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3239 and 3010 cm-1. The bands at 1657 cm-1 and 1612 cm-1 appear as 
intense bands corresponding to C=O carboxylic vibration, and C=C 
aromatic stretching bands. The spectra of phenylalanine from 3012 cm-1 
and 2957 cm-1 are the combination stretching vibration bands of O-H, N-
H, C-H aromatic and C-H aliphatic functional groups. It also clearly 
confirmed the presence of N-H···O and O-H···O hydrogen bonds from the 
broadband spectra from 3012 cm-1-2173 cm-1
 
 which fit well with the 
weak interactions from x-ray structure data. 
 
Fig. 3: The interactions of cocrystal contain inter-, intra-molecular and π−π interactions 
 
 
Fig. 4: The comparison FT-IR bands of salicylic, phenylalanine and cocrystal 
 
According to the cocrystallization (H 2Sal•Phe), the presence of 
stretching bands at 3397 cm-1 and 3188 cm-1 are strongly 
confirmed O-H, N-H functional groups. Moreover, N-H···O and O-
H···O hydrogen bonds also appeared as the broadband spectra 
from 3397 cm-1-2559 cm-1. As notice, the C=O bands of salicylic 
acid and phenylalanine are shifted to the lower or higher 
wavenumber by 2-28 cm-1 which suggested cocrystal of salicylic 
and phenylalanine [18]. By taking the previous work into account, 
our work shows no evidence of the strong bands at 1609 cm-1 
corresponding to [NH 3]+asymmetric deformation phenyl ring 
[18,19]. This is to indicate that our cocrystal does not consist of 
zwitterion characteristic but strongly confirm the neutral 
phenylalanine. In addition, the stretching C-O spectra of the 
carboxylic group of salicylic acid and phenylalanine have bands at 
1292 cm-1 and1310 cm-1 respectively. During the cocrystallization, 
these bands appeared at 1296 cm-1 
Formulation development of cosmetic creams containing 
pharmaceutical cocrystal (H
which indicated the carbonyl 
group participating in hydrogen bonding. 
2
Cosmetic preparation containing (H
Sal•Phe) 
2Sal•Phe) has developed as oil in 
water (o/w) creams because of spread easily and do not leave the 
skin greasy and sticky. In order to achieve this target, excipients 
formulation screening was necessary. The optimal formula should 
have the following characteristics: (i) it has previously been used as 
a clinical topical additive; (ii) it can comply with the product 
specifications as illustrated in table 6; and (iii) it passes the 
preliminary stability test by centrifugation test. In the present study, 
based on information in the Handbook of Pharmaceutical Excipients 
guidelines [37] and Handbook of Cosmetic Ingredients guidelines 
[38] on their use as additives for topical products, the formulations 
were developed. After trial and development of cream formulation, 
the full list of ingredients in the formulation as shown in table 2 with 
formulation codes are F1 to F4 with the reference F5 (without API). 
Cocrystal (H2Sal•Phe) was varied in the range of 0.25 to 1.0 % w/w. 
Phetmung et al. 
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Physical properties (appearance and homogeneity) 
The prepared formulations of chemical peeling cream from cocrystal 
(H2Sal•Phe) was inspected visually for color and homogeneity as 
shown in fig. 5. The pharmaceutical examination has been investigated 
all of 5 formulations. The appearance of cream of each formulation is 
not much different which is white, soft, smooth cream with a 
characteristic odor. The different concentration of (H2
Viscosity 
Sal•Phe) show 
slightly color, texture and viscosity of the products. The findings 
revealed that the freshly prepared creams were pale yellow, soft 
yellowish-white, yellow, white and yellowish-white for F1, F2, F3, F4 
and F5, respectively. Little changes in the color of all formulations may 
occur from the difference of cocrystal content in the formula. All 
formulations show excellent of homogeneity. The details of physical 
properties were shown in table 7. 
From the formulations, creams are developed by adjusting the 
amount of the substance in the formulation between 0-1% to find the 
appropriate amount on the purposes of a skin peeling effect and skin 
lightening. The substance formulation codes are F1 to F4 with the 
reference F5 as shown in table 6. Our preparation is based on the 
product specifications as illustrated in table 6. 
The pH determinations  
The 1% (w/w) of all formulations F1-F5 was in the pH value range of 
skin, according to table 7. As seen, F4 shows nearly pH neutral which 
appropriate for the application of this cream on the skin surface 
[39]. 
Dye solubility test 
Emulsion type (dye solubility), according to the results in table 7, 
every formulation are oil in water emulsions. That means our 
product facilitates the absorption of water-insoluble compounds 
comparing to their oily solution preparations (e. g. cream) as shown 
in fig. 6. 
Viscosity is the most important parameter in the evaluation as it governs 
the many properties of the formulation such as spreadability, pourability 
of the product from the container. The rheological behavior of the 
formulations was assessed by analysis of apparent viscosity, flow curve 
and hysteresis area. The apparent viscosity of cream formulation F1-F5 
was found to be 625, 634, 643, 639 and 627 Pa⋅s, respectively (table 7). 
Statistical analysis of the viscosity showed that they were not 
significantly different. The rheological behavior of the samples is shown 
as a shear-thinning system. As confirmed by the appearance of the plot of 
viscosity vs. shear rate, the creams exhibited thixotropic behavior, which 
is a desirable characteristic for topically applied products. In sum, the 
viscosity of F3 and F4 are quite higher than the others. 
Spreadability 
The cream base should spread easily without too much drag and 
should not produce greater friction in the rubbing process. The 
therapeutic efficacy of a formulation also depends on its spreading 
value. The results of spreadability are summarized in table 7. The 
values of spreadability indicate that the cream is easily spreadable by a 
small amount of shear. The results of spreadability were found to 
16.30, 15.59, 14.60, 15.18, and 17.32 g⋅cm/sec of the formulation F1 to 
F5, respectively. All formulations were not significantly differenced 
because cream base and ingredient are the same. Emollients used in 
the studied formulations were chosen according to their ability to 
properly spread when applied on skin, covering more area and 
protecting more skin tissue, and also according to their sensory 
properties, which should be pleasant to the user, such as the capability 
of the formulation to cause a dry and velvety feeling when applied. 
These characteristics can be found in volatile silicones so that the 
formulas were added cyclomethicone and dimethicone crosspolymer. 
The low value of spreadability of the cream indicates the lesser work 
required to spread the cream over the skin, which means formulation 
easily spreadable by applying a small amount of shear [40]. 
  
     
F1 F2 F3 F4 F5 
Fig. 5: The finished creams F1 to F5 
 




Appearance White, soft and smooth cream with a characteristic odor 
pH 4.0-6.0 
Homogeneity Excellent 
Viscosity (Pa⋅s) 500-1,000 
Microbial limit test Conform Thai FDA regulation 
 
Table 7: Physical characterization of a cream containing cocrystal (H2
Test parameter 
Sal•Phe) with control 
Formulation code 
F1 F2 F3 F4 F5 
Appearance Soft, smooth cream with a characteristic odor. 
Color Pale yellow Soft yellowish white Yellow White Yellowish white 
pH 4.82±0.02 4.98±0.02 5.10±0.05 5.23±0.10 4.80±0.03 
Homogeneity +++ +++ +++ +++ +++ 
Viscosity (Pa⋅s) 625±12 634±21 643±15 639±25 627±12 
Spreadability (g/sec) 16.30±0.02 15.59±0.01 14.60±0.05 15.18±0.02 17.32±0.26 
Emulsion type (dye solubility) o/w o/w o/w o/w o/w 
* mean ± SD = Standard Deviation from the mean, n = 6 
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F1 F4 F5 
Fig. 6: Dye solubility test shows only F1, F3 and F5 (control) 
 
Evaluation of the sun protection factor 
Sun protection factor (SPF) value is an indicator evaluating UVB 
protection efficacy of sunscreen product. The alternative method by in 
vitro assessment is less expensive and more efficient than in vivo assay 
by using human volunteers. As known, the SPF is a quantitative 
measurement of the effectiveness of a sunscreen formulation. 
Although cream containing (H2Sal•Phe) does not add sun protection 
ingredients, we observed the properties of sun protector when the 
formulation added cocrystal active substance. Fig. 7 shows the 
absorbance pattern of a cream containing cocrystal (H2
 
Sal•Phe). The 
results reveal that these formulations are quite low SPF value (<5, see 
table 8) because we didn’t add the sunscreen protection ingredients. 
According to reference [41], high SPF values are more difficult to 
measure. A high SPF normally leads to a greater uncertainty also in the 
final in vivo result, due to the biological variations of the volunteers. 
 
Fig. 7: The absorbance pattern of cream containing cocrystal (H2
 
Sal•Phe) 
Table 8: SPF study parameters of the formulations 
Test F1 F2 F3 F4 F5 
SPF 4.5 ± 0.2 4.5 ± 0.2 4.3 ± 0.1 4.6 ± 0.2 4.2 ± 0.2 
* mean ± SD = Standard Deviation from the mean, n = 6 
 
Stability study 
The purpose of the accelerated (centrifugation, freeze-thaw and 
40°C/75%RH) and long-term
After analyzing the results from table 9, the evaluation showed that 
the all formulation presented higher consistency of appearance 
(visual observation) for the centrifugation, accelerated test and 
freeze-thaw cycles conditions, and at the long-term for 3 mo. 
Liquefaction and phase separation was not observed in the cream 
preparation. The results indicated adequate stability, mainly in the 
high-temperature condition and good compatibility with the LDPE 
plastic packaging. The pH value presented very low variations of the 
initial specifications of this product in all conditions. Apparent 
viscosity from the accelerated stability study is described in table 9. 
All products showed viscosity values were decreased only storage at 
40°C/75%RH. The difference in the viscosity value variation in high 
temperature caused by stiffening agents in the formulation were 
melts. The assay content of salicylic acid in (H
 stability (30°C/75%RH) testing our 
cream is to ensure that our product meets the standard along with 
the shelf-life of the products and should be provided on at least 
three primary batches of the API. After formulation samples have 
undergone heat and physical stress at several periods of time, 
their resulting of colors was not change from initial of all 
formulations.  
2Sal•Phe) was found 
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that within the range of 95-102% labeled amount. This result 
confirms that the chemical stability of salicylic acid in the cocrystal 
form was stable after stress condition and long-term condition. In 
conclude according to table 9, all formulations were found to be 
stable with no sign of change in physical appearance, characteristic, 
and drug content. 
 
Table 9: Stability study parameters of the formulations  
Formulation Conditions Parameter evaluated 




F1 Centrifugation (28 d) - - - 5.03±0.02 NA NA 
 Freeze-Thaw (6 cycles) - - - 5.02±0.04 624±13 NA 
 30°C/75%RH (3 mo) - - - 5.03±0.02 642±12 96.28±0.23 
 40°C/75%RH (3 mo) - - - 5.04±0.01 572±32 95.13±0.92 
F2 Centrifugation (28 d) - - - 5.00±0.02 NA NA 
 Freeze-Thaw (6 cycles) - - - 5.04±0.01 622±12 NA 
 30°C/75%RH (3 mo) - - - 5.02±0.05 653±13 97.91±0.45 
 40°C/75%RH (3 mo) - - - 5.01±0.05 562±23 99.15±1.28 
F3 Centrifugation (28 d) - - - 5.04±0.02 NA NA 
 Freeze-Thaw (6 cycles) - - - 5.04±0.02 641±12 NA 
 30°C/75%RH (3 mo) - - - 5.04±0.04 642±22 102.53±1.16 
 40°C/75%RH (3 mo) - - - 5.01±0.07 571±25 98.74±1.25 
F4 Centrifugation (28 d) - - - 5.01±0.02 NA NA 
 Freeze-Thaw (6 cycles) - - - 5.04±0.03 644±42 NA 
 30°C/75%RH (3 mo) - - - 5.09±0.04 642±22 101.16±1.97 
 40°C/75%RH (3 mo) - - - 5.00±0.04 594±32 101.54±2.58 
F5 Centrifugation (28 d) - - - 5.03±0.02 NA NA 
 Freeze-Thaw (6 cycles) - - - 5.02±0.04 585±11 NA 
 30°C/75%RH (3 mo) - - - 5.20±0.12 585±22 96.86±0.12 
 40°C/75%RH (3 mo) - - - 4.83±0.20 542±32 98.55±2.33 
-= no change, NA = not applicable, * mean ± SD = Standard Deviation from the mean, n = 6  
 
Microbial limit test 
This test is designed to estimate the number of viable aerobic 
microorganisms present in a product and defines designated 
microbial species for products from the raw materials stage to a final 
manufactured product. Microbial limits testing for cosmetic and 
pharmaceutical products is an important part and to ensure the 
microbial safety of our cream for the consumer, maintain the quality 
of the product, and confirm the hygienic and the high-quality 
handling. We carry out routine microbiological of our finished 
product. Microbial limits testing for pharmaceutical products is an 
important part. The results showed no antibacterial effect with the 
evidence of low values of viable aerobic microorganisms and 
microbial species, as stated in table 10. Aerobic bacteria, 
Pseudomonas aeruginosa, Staphylococcus Aureus, yeast and molds 
are considered the main potential pathogens in cosmetic products. 
The chemical peeling cream results showed that results are under 
the Thai FDA regulation. The results showed no antibacterial effect 
with the evidence of low values of viable aerobic microorganisms 
and microbial species as stated in table 10. 
 
Table 10: Microbial load of aerobic plate count, P. spp, S. aureus and yeast and molds count of the formulations F4 (three replicates batch) 
Parameters Days of storage at room temperature 
0 14 28 
Aerobic plate count    
F1 2.00 ± 0.22 2.32 ± 0.31 2.38 ± 0.25 
F2 2.01 ± 0.24 2.24 ± 0.25 2.29 ± 0.20 
F3 3.04 ± 0.25 3.16 ± 0.23 3.33 ± 0.18 
F4 2.02 ± 0.30 2.42 ± 0.33 2.51 ± 0.30 
F5 1.06 ± 0.21 1.56 ± 0.25 1.84 ± 0.12 
P. spp    
F1 <1 <1 <1 
F2 <1 <1 <1 
F3 <1 <1 <1 
F4 <1 <1 <1 
F5 <1 <1 <1 
S. aureus    
F1 <1 <1 <1 
F2 <1 <1 <1 
F3 <1 <1 <1 
F4 <1 <1 <1 
F5 <1 <1 <1 
Yeast and molds    
F1 - - - 
F2 - - - 
F3 - - - 
F4 - - - 
F5 - - - 
-= No coliform detected, * mean ± SD = Standard Deviation from the mean, n = 3  
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Cytotoxicity test is designed to determine the toxicity to cells either 
qualitatively or quantitatively. The viability of BJ and HaCaT cell 
lines incubated with the H2Sal•Phe at a concentration of 0.5% were 
assessed on the toxicity of the cocrystal. More than 80 % of survival 
was recorded for the cocrystal (H2Sal•Phe). 
Patch test  
The skin irritation test was used to evaluate the skin irritation by the 
preparation cream to the intact skin. In this research, 10 women to 
apply the chemical peeling cream (F4) and compared them with 
other 10 women as a control that used chemical peeling cream 
without cocrystal (H2
Product satisfaction 
Sal•Phe) (F5). The results showed that no 
edema or erythema occurred in all 20 volunteers within 48 h. 
After 10 woman volunteers maintain using the product for 14 d, 
the questionnaire was an inquiry. Customer satisfaction listed in 
table 11 is a marketing term that measures how products or 
services supplied by a company meet or surpass a customer’s 
expectation. In this work, we choose 10 normal skin women (the 
same patch test group) to evaluate our product through a 
questionnaire after usage.  
Overall, the satisfaction levels of our product are high in each 
category. The questionnaire indicated that the most satisfactory of 
using our F4 cream was with 10% excellent, 80% very good, and 
10% good. In sum, we took F4 for further investigation, such as 
patch test and product satisfaction. 
 
Table 11: Product satisfaction of F4 
Parameter satification % 
Excellent (5) Very good (4) Good (3) Poor (2) Very poor (1) 
Ordor 20 70 10 0 0 
Colour 20 80 0 0 0 
Appearance 70 10 20 0 0 
Spreadiblilty after applied 30 40 20 10 0 
Viscosity after applied 30 60 10 0 0 
Brightening after applied 30 30 10 0 0 
Total satisfications 10 80 10 0 0 
 
CONCLUSION  
The goals of this study were to prepare new pharmaceutical cocrystal 
between salicylic acid and phenylalanine and aiming this cocrystal as an 
active ingredient to formulate the new chemical peeling or whitening 
cosmetics. We also successfully achieved these goals. The results both 
from the structure determination by single-crystal X-ray diffraction and 
from infrared spectra confirm cocrystal with no zwitterion on 
phenylalanine as the previous report. and strongly confirm cocrystal. 
The inter-, intra-molecular interactions and π-π interactions stabilized 
the structure. Cocrystal (H2Sal•Phe) was formulated in chemical peeling 
cream by conventional beaker method with general ingredients for 
pharmaceutical or cosmetic cream. From the pharmaceutical 
investigation such as appearances, physical and chemical properties. The 
chemical peeling cream containing cocrystal (H2Sal•Phe) has shown the 
promising results which are both safe and efficacious peeling agent. 
Cocrystal (H2
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